These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 22272361)
1. A functional NQO1 609C>T polymorphism and risk of gastrointestinal cancers: a meta-analysis. Yu H; Liu H; Wang LE; Wei Q PLoS One; 2012; 7(1):e30566. PubMed ID: 22272361 [TBL] [Abstract][Full Text] [Related]
2. Effects of the NQO1 609C>T polymorphism on leukemia susceptibility: evidence from a meta-analysis. Han FF; Guo CL; Gong LL; Jin Z; Liu LH Asian Pac J Cancer Prev; 2013; 14(9):5311-6. PubMed ID: 24175818 [TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphism 609C>T in NAD(P)H:quinone oxidoreductase 1 enhances the risk of proximal colon cancer. Freriksen JJ; Salomon J; Roelofs HM; Te Morsche RH; van der Stappen JW; Dura P; Witteman BJ; Lacko M; Peters WH J Hum Genet; 2014 Jul; 59(7):381-6. PubMed ID: 24830960 [TBL] [Abstract][Full Text] [Related]
4. "NQO1 Gene C609T Polymorphism (dbSNP: rs1800566) and Digestive Tract Cancer Risk: A Meta-Analysis.". Yadav U; Kumar P; Rai V Nutr Cancer; 2018; 70(4):557-568. PubMed ID: 29652514 [TBL] [Abstract][Full Text] [Related]
5. Association between NAD(P)H:quinone oxidoreductase 1 rs1800566 polymorphism and risk of bladder cancer. Zhang H; Wen X; Lu X; Zhang H Tumour Biol; 2013 Dec; 34(6):3377-81. PubMed ID: 23873104 [TBL] [Abstract][Full Text] [Related]
6. The NQO1 rs1800566 polymorphism and risk of bladder cancer: evidence from 6,169 subjects. Guo ZJ; Feng CL Asian Pac J Cancer Prev; 2012; 13(12):6343-8. PubMed ID: 23464456 [TBL] [Abstract][Full Text] [Related]
7. Association between NQO1 C609T polymorphism and colorectal cancer risk. Wang Y; Zhang G; Luo Y Tumour Biol; 2013 Dec; 34(6):4027-32. PubMed ID: 23893397 [TBL] [Abstract][Full Text] [Related]
8. The NQO1 C609T polymorphism and risk of lung cancer: a meta-analysis. Liu Y; Zhang D Asian Pac J Cancer Prev; 2011; 12(11):3091-5. PubMed ID: 22393995 [TBL] [Abstract][Full Text] [Related]
9. Association of NQO1 levels and its genetic polymorphism with susceptibility to methamphetamine dependence. Liu H; Zhang W; Deng XD; Ma Y; Liu Y Mol Genet Genomic Med; 2021 Oct; 9(10):e1789. PubMed ID: 34467676 [TBL] [Abstract][Full Text] [Related]
10. Genetic association of NQO1 609C>T polymorphism with risk of gastrointestinal cancer: evidence from case-control studies. Liu H; Zhou S; Ma L; Yang J; Yang H Int J Clin Exp Med; 2015; 8(4):6046-52. PubMed ID: 26131202 [TBL] [Abstract][Full Text] [Related]
11. Role of NQO1 609C>T and NQO2 -3423G>A gene polymorphisms in esophageal cancer risk in Kashmir valley and meta analysis. Malik MA; Zargar SA; Mittal B Mol Biol Rep; 2012 Sep; 39(9):9095-104. PubMed ID: 22736108 [TBL] [Abstract][Full Text] [Related]
12. Association of NQO1 rs1800566 polymorphism and the risk of colorectal cancer: a meta-analysis. Ding R; Lin S; Chen D Int J Colorectal Dis; 2012 Jul; 27(7):885-92. PubMed ID: 22215148 [TBL] [Abstract][Full Text] [Related]
13. Null association of NQO1 609C>T and NQO2 -3423G>A polymorphisms with susceptibility and prognosis of Esophageal cancer in north Indian population and meta-analysis. Umar M; Upadhyay R; Kumar S; Ghoshal UC; Mittal B Cancer Epidemiol; 2012 Dec; 36(6):e373-9. PubMed ID: 22770696 [TBL] [Abstract][Full Text] [Related]
14. NAD(P)H quinone oxidoreductase 1 (NQO1) genetic C609T polymorphism is associated with the risk of digestive tract cancer: a meta-analysis based on 21 case-control studies. Yang FY; Guan QK; Cui YH; Zhao ZQ; Rao W; Xi Z Eur J Cancer Prev; 2012 Sep; 21(5):432-41. PubMed ID: 22387672 [TBL] [Abstract][Full Text] [Related]
15. Association of NAD (P) H Quinine Oxidoreductase 1 rs1800566 Polymorphism with Bladder and Prostate Cancers - a Systematic Review and Meta-Analysis. Abedinzadeh M; Moghimi M; Dastgheib SA; Maleki H; Salehi E; Zare M; Jarahzadeh HM; Neamatzadeh H Klin Onkol; 2020; 33(2):92-100. PubMed ID: 32303129 [TBL] [Abstract][Full Text] [Related]
16. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T gene polymorphism association with digestive tract cancer: a meta-analysis. Zhu CL; Huang Q; Liu CH; Lin XS; Xie F; Shao F Asian Pac J Cancer Prev; 2013; 14(4):2349-54. PubMed ID: 23725139 [TBL] [Abstract][Full Text] [Related]
17. NAD(P)H: quinone oxidoreductase 1 gene rs1800566 polymorphism increases the risk of cervical cancer in a Chinese Han sample: A STROBE-complaint case-control study. Yang S; Zhao J; Li L Medicine (Baltimore); 2020 May; 99(20):e19941. PubMed ID: 32443295 [TBL] [Abstract][Full Text] [Related]
18. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and lung cancer risk: a meta-analysis. Lou Y; Li R; Xiong L; Gu A; Shi C; Chu T; Zhang X; Gu P; Zhong H; Wen S; Han B Tumour Biol; 2013 Dec; 34(6):3967-79. PubMed ID: 23852860 [TBL] [Abstract][Full Text] [Related]
19. Role of NADPH Quinone Reductase 1 (NQO1) Polymorphism in Prevention, Diagnosis, and Treatment of Gastrointestinal Cancers. Ghorbani F; Mazidimoradi A; Biyabani A; Allahqoli L; Salehiniya H Curr Cancer Drug Targets; 2024; 24(12):1213-1221. PubMed ID: 38318828 [TBL] [Abstract][Full Text] [Related]
20. NQO1 609C>T polymorphism interaction with tobacco smoking and alcohol drinking increases colorectal cancer risk in a Chinese population. Peng XE; Jiang YY; Shi XS; Hu ZJ Gene; 2013 May; 521(1):105-10. PubMed ID: 23458878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]